| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC | Chief Financial Officer | Common Stock | 267K | $1.49M | $5.57 | May 14, 2024 | Direct |
| BIOCRYST PHARMACEUTICALS INC | Chief Financial Officer | Emp. Stock Option (Right to Buy) | 159K | Dec 14, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | May 14, 2024 | 1 | $202K | 4 | May 15, 2024 | Chief Financial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 19, 2023 | 1 | -$15K | 4 | Dec 20, 2023 | Chief Financial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 14, 2023 | 3 | -$35.2K | 4 | Dec 18, 2023 | Chief Financial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 19, 2022 | 2 | $0 | 4 | Dec 21, 2022 | Chief Financial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 15, 2022 | 1 | -$62.1K | 4 | Dec 19, 2022 | Chief Financial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 14, 2021 | 1 | $0 | 4/A | Jan 13, 2022 | Chief Financial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Nov 23, 2021 | 1 | $440K | 4 | Nov 24, 2021 | Chief Financial Officer |